ECDA vs DRVN vs MCRB vs HLLY vs CVNA

For growth investors, Carvana Co.

(CVNA) is the stronger pick with 48. 6% revenue growth year-over-year, versus 1. 5% for Driven Brands Holdings Inc. (DRVN). Seres Therapeutics, Inc. (MCRB) offers the better valuation at 12. 1x trailing P/E, making it the more compelling value choice. Analysts rate Driven Brands Holdings Inc. (DRVN) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Seres Therapeutics, Inc.

(MCRB) is the cheapest at 12. 1x versus Carvana Co. at 47. 4x. On forward P/E, Holley Inc. is actually cheaper at 7. 4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Carvana Co.

(CVNA) delivered a total return of +61. 5%, compared to -100. 0% for ECD Automotive Design, Inc. (ECDA). Over 10 years, the gap is even starker: CVNA returned +35. 1% versus ECDA's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Driven Brands Holdings Inc.

(DRVN) is the lower-risk stock at 0. 68β versus Carvana Co. 's 2. 14β — meaning CVNA is approximately 213% more volatile than DRVN relative to the S&P 500. On balance sheet safety, Carvana Co. (CVNA) carries a lower debt/equity ratio of 15% versus 7% for Driven Brands Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Carvana Co.

(CVNA) is pulling ahead at 48. 6% versus 1. 5% for Driven Brands Holdings Inc. (DRVN). On earnings-per-share growth, the picture is similar: Carvana Co. grew EPS 431. 4% year-over-year, compared to -540. 0% for ECD Automotive Design, Inc.. Over a 3-year CAGR, ECDA leads at 29. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Seres Therapeutics, Inc.

(MCRB) is the more profitable company, earning 721. 9% net margin versus -42. 8% for ECD Automotive Design, Inc. — meaning it keeps 721. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLLY leads at 14. 3% versus -119. 1% for MCRB. At the gross margin level — before operating expenses — DRVN leads at 52. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Holley Inc.

(HLLY) trades at 7. 4x forward P/E versus 51. 4x for Carvana Co. — 44. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLLY: 148. 0% to $6. 25.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Driven Brands Holdings Inc.

(DRVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 68)). Holley Inc. (HLLY) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DRVN: -48. 5%, HLLY: -74. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ECDA (Consumer Cyclical) and DRVN (Consumer Cyclical) and MCRB (Healthcare) and HLLY (Consumer Cyclical) and CVNA (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ECDA is a small-cap high-growth stock; DRVN is a small-cap quality compounder stock; MCRB is a small-cap deep-value stock; HLLY is a small-cap deep-value stock; CVNA is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.